Literature DB >> 29362904

Atrial Fibrillation Ablation and its Impact on Stroke.

Kevin G Graves1,2, Victoria Jacobs1, Heidi T May1, Michael J Cutler1, John D Day1, T Jared Bunch3,4,5.   

Abstract

Atrial fibrillation (AF) is a commonly encountered arrhythmia, which is not yet fully understood. Catheter ablation has shown to be an effective strategy for rhythm management and several small or retrospective studies have shown that stroke rates are decreased in ablated AF patients compared to those medically managed. Several studies even show that ablation returns stroke risk to that of non-AF patients. Large scale, prospective trials will further illuminate this connection and provide mechanistic understanding of the role of the procedure versus the process of selection for the procedure and peri- and post-procedural therapy and management. Furthermore, modification of risk factors associated with AF show a significant increase in the sustained success of AF ablation and can also moderate the progression of AF.

Entities:  

Keywords:  Arrhythmia; Atrial fibrillation; Catheter ablation; Stroke

Year:  2018        PMID: 29362904     DOI: 10.1007/s11936-018-0596-0

Source DB:  PubMed          Journal:  Curr Treat Options Cardiovasc Med        ISSN: 1092-8464


  55 in total

1.  Exercise Training and Atrial Fibrillation: Further Evidence for the Importance of Lifestyle Change.

Authors:  Adrian D Elliott; Rajiv Mahajan; Rajeev K Pathak; Dennis H Lau; Prashanthan Sanders
Journal:  Circulation       Date:  2016-01-05       Impact factor: 29.690

2.  The risk of thromboembolism and need for oral anticoagulation after successful atrial fibrillation ablation.

Authors:  Sakis Themistoclakis; Andrea Corrado; Francis E Marchlinski; Pierre Jais; Erica Zado; Antonio Rossillo; Luigi Di Biase; Robert A Schweikert; Walid I Saliba; Rodney Horton; Prasant Mohanty; Dimpi Patel; David J Burkhardt; Oussama M Wazni; Aldo Bonso; David J Callans; Michel Haissaguerre; Antonio Raviele; Andrea Natale
Journal:  J Am Coll Cardiol       Date:  2010-02-23       Impact factor: 24.094

Review 3.  2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society.

Authors:  Craig T January; L Samuel Wann; Joseph S Alpert; Hugh Calkins; Joaquin E Cigarroa; Joseph C Cleveland; Jamie B Conti; Patrick T Ellinor; Michael D Ezekowitz; Michael E Field; Katherine T Murray; Ralph L Sacco; William G Stevenson; Patrick J Tchou; Cynthia M Tracy; Clyde W Yancy
Journal:  J Am Coll Cardiol       Date:  2014-03-28       Impact factor: 24.094

4.  Incidence and long-term follow-up of silent cerebral lesions after pulmonary vein isolation using a remote robotic navigation system as compared with manual ablation.

Authors:  Andreas Rillig; Udo Meyerfeldt; Roland Richard Tilz; Jochen Talazko; Anita Arya; Vlada Zvereva; Ralf Birkemeyer; Tomislav Miljak; Bajram Hajredini; Peter Wohlmuth; Ulrich Fink; Werner Jung
Journal:  Circ Arrhythm Electrophysiol       Date:  2012-01-13

5.  Atrial fibrillation as a predictive factor for severe stroke and early death in 15,831 patients with acute ischaemic stroke.

Authors:  K Kimura; K Minematsu; T Yamaguchi
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-05       Impact factor: 10.154

6.  Impact of metabolic syndrome on procedural outcomes in patients with atrial fibrillation undergoing catheter ablation.

Authors:  Sanghamitra Mohanty; Prasant Mohanty; Luigi Di Biase; Rong Bai; Agnes Pump; Pasquale Santangeli; David Burkhardt; Joseph G Gallinghouse; Rodney Horton; Javier E Sanchez; Shane Bailey; Jason Zagrodzky; Andrea Natale
Journal:  J Am Coll Cardiol       Date:  2012-04-03       Impact factor: 24.094

7.  Risk of early death and recurrent stroke and effect of heparin in 3169 patients with acute ischemic stroke and atrial fibrillation in the International Stroke Trial.

Authors:  R Saxena; S Lewis; E Berge; P A Sandercock; P J Koudstaal
Journal:  Stroke       Date:  2001-10       Impact factor: 7.914

8.  Analysis of stroke in ATHENA: a placebo-controlled, double-blind, parallel-arm trial to assess the efficacy of dronedarone 400 mg BID for the prevention of cardiovascular hospitalization or death from any cause in patients with atrial fibrillation/atrial flutter.

Authors:  Stuart J Connolly; Harry J G M Crijns; Christian Torp-Pedersen; Martin van Eickels; Christophe Gaudin; Richard L Page; Stefan H Hohnloser
Journal:  Circulation       Date:  2009-09-14       Impact factor: 29.690

9.  Warfarin is not needed in low-risk patients following atrial fibrillation ablation procedures.

Authors:  T Jared Bunch; Brian G Crandall; J Peter Weiss; Heidi T May; Tami L Bair; Jeffrey S Osborn; Jeffrey L Anderson; Donald L Lappe; J Brent Muhlestein; Jennifer Nelson; Scott Allison; Thomas Foley; Lars Anderson; John D Day
Journal:  J Cardiovasc Electrophysiol       Date:  2009-05-15

10.  The role of CHADS2 and CHA2 DS2 -VASc scores in the prediction of stroke in individuals without atrial fibrillation: a population-based study.

Authors:  W Saliba; N Gronich; O Barnett-Griness; G Rennert
Journal:  J Thromb Haemost       Date:  2016-05-31       Impact factor: 5.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.